A bill for an act relating to the controlled substance crystalline polymorph psilocybin.

HF 14 would remove the pharmaceutical form of psilocybin (specifically crystalline polymorph psilocybin, also known as COMP 360) from Iowa's Schedule I controlled substances list once approved by the U.S. Food and Drug Administration (FDA). It directs Iowa to align with federal rescheduling under the Controlled Substances Act, making it lawful to prescribe, distribute, and market this specific pharmaceutical product after FDA approval. The bill directly affects medical providers, pharmacies, and pharmaceutical companies seeking to legally offer this approved treatment. It does not change current penalties for non-pharmaceutical psilocybin possession, which remain classified as a serious misdemeanor or class B felony.